Retinal Degeneration Fund

The Retinal Degeneration Fund (RD Fund), a 501(c)(3) not-for-profit subsidiary of the Foundation Fighting Blindness, was established in 2018 to serve the Foundation’s mission to rapidly drive research toward preventions, treatments, and cures for the entire spectrum of blinding retinal diseases —including retinitis pigmentosa, macular degeneration, and Usher syndrome. RD Fund focuses on mission-related investments in companies with projects nearing clinical testing. The RD Fund aims to deliver life-changing solutions for individuals with retinal degenerative diseases today, while also creating a pipeline of next-generation and novel therapeutic opportunities for tomorrow. The RD Fund is flexible in how it structures investments leveraging equity, debt, royalty, and/or project co-funding. All proceeds of this high-impact philanthropic vehicle are returned back to the Foundation to provide resources to further its mission.